Study to Evaluate the Efficacy and Safety of KBP-042 in Patients With Type 2 Diabetes
Clinical trial NCT03230786 · COMPLETED
Trial details
- NCT number
- NCT03230786
- Sponsor
- KeyBioscience AG
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-23
- Primary completion
- 2018-07-09
- Enrollment
- 255
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.